Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
The Nominees for Best Biopharma CEO of 2015 Are...
By Adam Feuerstein
Dec 15, 2015 8:14 AM EST
INVESTING
Bluebird, Pacira Pharmaceuticals Excite Life Science Investors
By Scott Gamm
Aug 12, 2015 5:42 PM EDT
VIDEO
Bluebird, Pacira Pharmaceuticals Gain Steam in Burgeoning Life Science Space
By Scott Gamm
Aug 12, 2015 5:00 PM EDT
MARKETS
New Lifetime High Today: Synageva BioPharma (GEVA)
By TheStreet Wire
Jun 19, 2015 9:47 AM EDT
STOCKS
4 Big Biotech Companies to Sell Now
By Laurie Kulikowski
May 26, 2015 8:30 AM EDT
INVESTING
Jim Cramer -- Stock Market's Takeover Frenzy Won't End Anytime Soon
By Jim Cramer
May 19, 2015 9:34 AM EDT
MARKETS
Trade-Ideas: Synageva BioPharma (GEVA) Is Today's Unusual Social Activity Stock
By TheStreet Wire
May 7, 2015 10:54 AM EDT
INVESTING
Jim Cramer -- Why Is Janet Yellen Suddenly a Stock Commentator?
By Jim Cramer
May 7, 2015 9:01 AM EDT
STOCKS
Fear of a 'Soliris Killer' Might Have Driven Alexion to Overpay for Synageva
By Adam Feuerstein
May 7, 2015 5:45 AM EDT
VIDEO
Microsoft Lags Dow in Tech Selloff; Yellen Spooks Wall Street
By Keris Alison Lahiff
May 6, 2015 4:40 PM EDT
MARKETS
Yellen Warning About Overvalued Stocks Spooks Wall Street
By Keris Alison Lahiff
May 6, 2015 4:11 PM EDT
JIM CRAMER
Cablevision Eyes Consolidation, Biotech Seen Nearing Bubble
By Dawn Kawamoto
May 6, 2015 3:33 PM EDT
MARKETS
Stocks Slump on Comments From Fed's Yellen; Herbalife Soars
By Keris Alison Lahiff
May 6, 2015 2:49 PM EDT
MARKETS
Synageva Biopharma (GEVA) Stock More Than Doubles to 52-Week High on Alexion Acquisition
By Andrew Meola
May 6, 2015 1:59 PM EDT
MARKETS
Alexion Pharmaceuticals (ALXN) Stock Falls After Agreeing to Acquire Synageva Biopharma
By Andrew Meola
May 6, 2015 1:38 PM EDT
INVESTING
How to Trade the Market's Most Active Stocks
By Jonas Elmerraji
May 6, 2015 1:23 PM EDT
MARKETS
Stocks Pare Losses in Choppy Session; Crude Gains as Inventories Drop
By Keris Alison Lahiff
May 6, 2015 11:32 AM EDT
VIDEO
Herbalife Beats Estimates; Stocks Open Slightly Higher as Crude Rallies
By Keris Alison Lahiff
May 6, 2015 10:20 AM EDT
STOCKS
Alexion Pays Hefty $8.4 Billion to Acquire Synageva, Expand Rare Disease Drug Business
By Adam Feuerstein
May 6, 2015 8:35 AM EDT
MARKETS
Stock Futures Set Up Small Rebound as Crude Oil Touches $62
By Keris Alison Lahiff
May 6, 2015 8:27 AM EDT
MARKETS
Synageva BioPharma (GEVA) Moving On Heavy Volume In The Pre-Market Hours
By TheStreet Wire
May 6, 2015 8:13 AM EDT
MARKETS
Today's Weak On High Volume Stock: Synageva BioPharma (GEVA)
By Marissa Goodbody
Mar 26, 2015 10:03 AM EDT
MARKETS
Synageva BioPharma (GEVA) Moving On Heavy Volume In The Pre-Market Hours
By Jamie Hodge
Jan 7, 2015 9:14 AM EST
MARKETS
Synageva BioPharma (GEVA) Showing Signs Of Perilous Reversal Today
By Scott Olson
Jan 6, 2015 10:38 AM EST
INVESTING
Some Potential Targets for Shire to Buy With $1.6B in Free Money
By Adam Feuerstein
Oct 21, 2014 9:29 AM EDT
